"MicroGenDX is Introducing PerioDX, the First Commercially Available Saliva-Based qPCR+NGS Test for Oral Health"

Cardiovascular Disease and the Oral Microbiome

  1. Bale, Bradley Field et al. “High-risk periodontal pathogens contribute to the pathogenesis of atherosclerosis.” Postgraduate medical journal vol. 93,1098 (2017): 215-220. doi:10.1136/postgradmedj-2016-134279
  2. Leishman, Shaneen J et al. “Cardiovascular disease and the role of oral bacteria.” Journal of oral microbiology vol. 2 10.3402/jom. v 2i0.5781. 21 Dec. 2010, doi:10.3402/jom. v2i0.5781
  3. Mustapha, Indra Z et al. “Markers of systemic bacterial exposure in periodontal disease and cardiovascular disease risk: a systematic review and meta-analysis.” Journal of periodontology vol. 78,12 (2007): 2289-302. doi:10.1902/jop.2007.070140
  4. Humphrey, Linda L et al. “Periodontal disease and coronary heart disease incidence: a systematic review and meta-analysis.” Journal of general internal medicine vol. 23,12 (2008): 2079-86. doi:10.1007/s11606-008-0787-6
  5. Murakami, Minoru et al. “High incidence of Aggregatibacter actinomycetemcomitans infection in patients with cerebral infarction and diabetic renal failure: a cross-sectional study.” BMC infectious diseases vol. 13 557. 24 Nov. 2013, doi:10.1186/1471-2334-13-557
  6. Wassef, Nancy et al. “HACEK-induced endocarditis.” BMJ case reports vol. 2013 bcr2012007359. 15 May. 2013, doi:10.1136/bcr-2012-007359